• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

15
1
1
1
1

COUNTRY

1

CATEGORIES

  • 5
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

6
10
13
21

PUBLISHED

2
3
5
21

PRODUCT TYPE

14
5
1
1

Search "Outcome Measures in Alzheimer's Disease" returned 21 results.

PRODUCT TITLE

Alzheimer's Disease – Pipeline Review, H1 2013

Global Markets Direct's, 'Alzheimer's Disease - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development...

February 2013
FROM
Targacept’s TC-5619 - The prospects for this fully-owned alpha-7 neuronal nicotinic receptor agonist Targacept’s TC-5619 - The prospects for this fully-owned alpha-7 neuronal nicotinic receptor agonist - Product Thumbnail Image

Targacept’s TC-5619 - The prospects for this fully-owned alpha-7 neuronal nicotinic receptor agonist

Earlier this year, Targacept reported that its phase II proof of concept study of TC-5619 in cognitive dysfunction in schizophrenia (CDS) met the pre-specified primary endpoint, while the trial in ADHD...

May 2011
FROM
Alzheimer's Disease - Pipeline Review, H2 2012 Alzheimer's Disease - Pipeline Review, H2 2012 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2012

Alzheimer's Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H2 2012', provides an overview of the Alzheimer's Disease therapeutic pipeline....

August 2012
FROM

Alzheimer's Disease - Pipeline Review, H2 2013

'Alzheimer's Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Alzheimer's Disease,...

August 2013
FROM
Global Clinical Trials for Alzheimer's Disease Global Clinical Trials for Alzheimer's Disease - Product Thumbnail Image

Global Clinical Trials for Alzheimer's Disease

Global Clinical Trials for Alzheimer's Disease is a handy one-stop reference for researchers and physicians planning and conducting global clinical trials in this area. This book addresses important...

November 2013
Alzheimer's Disease - Pipeline Review, H1 2012 Alzheimer's Disease - Pipeline Review, H1 2012 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H1 2012

Alzheimer's Disease – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H1 2012', provides an overview of the Alzheimer's Disease therapeutic pipeline....

February 2012
FROM
Neuroprotection - Drugs, Markets and Companies Neuroprotection - Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

April 2014
FROM

Alzheimer's Disease - Pipeline Review, H1 2014

Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This...

February 2014
FROM

Alzheimer's Disease - Pipeline Review, Q4 2010

Alzheimer's Disease - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Alzheimer's Disease Pipeline Review, Q4 2010”, provides an overview of the Alzheimer's Disease therapeutic pipeline....

December 2010
FROM

Alzheimer's Disease - Pipeline Review, H2 2011

Alzheimer's Disease - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H2 2011', provides an overview of the Alzheimer's Disease therapeutic pipeline....

September 2011
FROM

Alzheimer's Disease - Pipeline Review, Q1 2011

Alzheimer's Disease - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, Q1 2011', provides an overview of the Alzheimer's Disease therapeutic pipeline....

February 2011
FROM
Global Biopharma Outlook 2011: Major US and EU Global Biopharma Outlook 2011: Major US and EU - Product Thumbnail Image

Global Biopharma Outlook 2011: Major US and EU

The year 2011 and 2012 will be a bonanza for generic companies, as large innovator companies will lose patent exclusivity on prescription drugs worth over $70b in sales It is imperative to understand...

February 2011
FROM

Global Clinical Trials Playbook

Pharmaceuticals companies, biotech companies, and CROs, regardless of size, all face the same challenge of managing costs and operational execution associated with bringing a valuable drugs and devices to...

May 2012
Emerging Medical Technologies Spotlight Emerging Medical Technologies Spotlight - Product Thumbnail Image

Emerging Medical Technologies Spotlight

Emerging Medical Technologies (EMT) Spotlight ® is a resource for strategic marketing, market research, business development, and investment executives seeking discreet and detailed business, market,...

April 2014
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010 Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010 - Product Thumbnail Image

Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010

This report includes details on over 300 emerging medical technology companies that: have presented at a 2010 Elsevier/Medtech Insight In3 investor/partnering conference; have presented at a 2010 LSI...

January 2011
FROM
Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics - Product Thumbnail Image

Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics

High clinical development costs coupled with declining drug discovery success rates have meant that pharmaceutical companies must re-evaluate their drug development process in order to reduce attrition...

May 2006
FROM
BG Medicine, Inc. Product Pipeline Analysis BG Medicine, Inc. Product Pipeline Analysis - Product Thumbnail Image

BG Medicine, Inc. Product Pipeline Analysis

BG Medicine, Inc. Product Pipeline Analysis Summary This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also...

January 2009
FROM

Principles and Practice of Geriatric Psychiatry. 3rd Edition

The renowned Principles and Practice of Geriatric Psychiatry, now in its third edition, addresses the social and biological concepts of geriatric mental health from an international perspective. Featuring...

December 2010
2010 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 2010 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

2010 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on over 300 emerging medical technology companies that: have presented at a 2010 Elsevier/Medtech Insight In3 investor/partnering conference; have presented at a 2010 LSI...

December 2010
FROM

Tutorials in Biostatistics. Statistical Methods in Clinical Studies. Volume 1

The Tutorials in Biostatistics have become a very popular feature of the prestigious Wiley journal, Statistics in Medicine (SIM). The introductory style and practical focus make them accessible to a...

August 2004
Loading Indicator